Please do not leave this page until complete. This can take a few moments.
Harvard Pilgrim, which has been selling group policies in Connecticut since 2014, said Wednesday that it has signed an outcomes-based agreement with drugmaker AstraZeneca.
Under the terms, the not-for-profit health insurer will cover the asthma and chronic obstructive pulmonary disease drug Symbicort.
If patient symptoms, including those that require medical intervention, are in line with those observed in a previous clinical trial, Harvard Pilgrim will pay AstraZeneca a higher reimbursement. If they are not in line with those results, the reimbursement will be lower, the insurer said.
Harvard Pilgrim has now signed three such contracts with AstraZeneca in the past two years, and a number of deals with other drugmakers. Another, which was announced early this year, is related to a gene therapy treatment, Luxturna, developed by Spark Therapeutics to treat inherited forms of blindness.
“We believe that outcomes and value-based contracts are one way to begin to address the need for greater focus on value in our health system,” Dr. Michael Sherman, Harvard’s chief medical officer, said in a statement.
The Hartford Business Journal 2025 Charity Event Guide is the annual resource publication highlighting the top charity events in 2025.
Learn moreHartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
SubscribeDelivering vital marketplace content and context to senior decision-makers throughout Connecticut ...
All Year Long!
The Hartford Business Journal 2025 Charity Event Guide is the annual resource publication highlighting the top charity events in 2025.
Hartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
Delivering vital marketplace content and context to senior decision-makers throughout Connecticut ...
All Year Long!
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments